NRX-101 or Lurasidone for Depression in People With Bipolarity
About this title
NRX-101 for Bipolar Depression With Subacute Suicidal Ideation
Read the official source — NCT03395392Researchers compared NRX-101 and Lurasidone HCl to find out how the approaches affected depression symptoms in adults with bipolarity during a depressive episode.
Understand this study
What did researchers investigate?
Researchers compared NRX-101 and Lurasidone HCl to find out how the approaches affected depression symptoms in adults with bipolarity during a depressive episode.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Culver City and 13 more locationsSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 74
- Sponsor
- NeuroRx, Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT03395392
- Official title
Show the full official title
A Randomized, Double-Blind Controlled Comparison of NRX-101 to Lurasidone for Adults With Bipolar Depression and Subacute Suicidal Ideation or Behavior
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Culver City · Miami Lakes · Atlanta
10 more locations
- Decatur
- Savannah
- Gaithersburg
- Omaha
- Amherst
- Eugene
- Austin
- Fort Worth
- Houston
- Richmond
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared NRX-101 and Lurasidone HCl to find out how the approaches affected depression symptoms in adults with bipolarity during a depressive episode.
Who is behind this study?
The study sponsor is NeuroRx, Inc.
Did this study involve medication?
Yes. The study involved medication, including NRX-101 and Lurasidone HCl.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
